Farxiga and Finasteride Interaction: Safety, Risks, and Clinical Guidance

How the medicines are processed

Dapagliflozin, the active ingredient in Farxiga, is metabolized mainly through UGT1A9. Finasteride is metabolized mainly through CYP3A4. These are different primary metabolic pathways. The practical review should focus on each drug's labeled interactions and the full medication list.

Neither current label names the other medicine as an interaction requiring a specific adjustment. The finasteride label reports no clinically important interactions identified in its studies; that wording should not be expanded into a guarantee covering every untested drug combination. Sources: Farxiga prescribing information, Proscar prescribing information.

The side-effect figures below come from the individual drug trials. Use them with the dose, indication and medical history relevant to your prescription.

Confirm which prescription you take

Farxiga may be prescribed for type 2 diabetes, heart failure or chronic kidney disease. Its heart-failure use is not restricted in the current label to reduced ejection fraction. Finasteride 5 mg, sold as Proscar, treats symptomatic enlarged prostate; finasteride 1 mg, sold as Propecia, treats male pattern hair loss. Those doses and populations are different. Farxiga, Proscar, Propecia.

Bring the bottles or a current list to the review. Include combination tablets, nonprescription medicines and treatments supplied by another clinician. The name of a condition alone does not establish which formulation or dose you use.

Sexual symptoms and genital infection are different problems

Finasteride can affect libido, erections and ejaculation. In the first-year Propecia hair-loss trials, one or more specified sexual adverse experiences occurred in 3.8% of 945 men taking finasteride 1 mg and 2.1% of 934 taking placebo. These figures describe those trials, not people taking finasteride with Farxiga, and they should not be substituted for the 5 mg BPH data. Persistent sexual symptoms have also been reported after stopping finasteride; spontaneous reports cannot establish their frequency. Propecia prescribing information.

Farxiga-associated genital yeast infections are a separate issue. Itching, redness or discharge should prompt medical advice. Severe tenderness, swelling or redness around the genitals or perineum, especially with fever or feeling very unwell, needs immediate assessment for a rare serious infection called Fournier's gangrene. Do not assume these symptoms are finasteride-related sexual side effects. Farxiga infection warnings.

Describe what happened, when it began and which medicines changed. A new symptom can have more than one cause; choosing a treatment depends on identifying it correctly.

The rest of the medication list matters

Farxiga can contribute to fluid loss and dizziness. Vomiting, diarrhea, poor intake, heat exposure and other medicines can change the practical risk. Tell your care team if you cannot eat or drink normally and ask for a specific sick-day plan. MedlinePlus dapagliflozin information.

The Farxiga label calls out insulin and insulin-releasing medicines because of hypoglycemia risk, and lithium because its concentration may decrease. Diuretics also matter when assessing volume depletion. A normal-looking two-drug interaction check does not replace reviewing these additional medicines. Farxiga prescribing information.

Kidney testing and PSA monitoring answer different questions

Farxiga requires kidney-function assessment before initiation and thereafter as clinically indicated. Finasteride does not require renal dose adjustment according to its label. There is no universal extra blood-test panel simply because these two medicines are combined. The reason for treatment, kidney function, symptoms and other medicines determine follow-up.

For finasteride 5 mg, PSA falls by about half within six months on average. The Proscar label directs clinicians to establish a new baseline after at least six months and evaluate a confirmed rise from the lowest value. For an isolated PSA after six months or longer, the label uses doubling to compare with untreated reference ranges. Tell the clinician interpreting the test about finasteride rather than adjusting a result yourself. Proscar prescribing information.

Finasteride 1 mg can also lower PSA. Its use for hair loss is still relevant to anyone interpreting that test. Propecia prescribing information.

Surgery and symptoms that should not wait

Dapagliflozin can be associated with ketoacidosis even when glucose is not especially high. Stop taking it and get urgent medical help for symptoms such as nausea or vomiting with abdominal pain, marked tiredness or breathing difficulty. A reassuring glucose reading does not rule this out. Discuss planned surgery in advance: dapagliflozin is generally withheld for at least three days before surgery, and the treating team should set the restart plan. MedlinePlus.

Taking finasteride does not remove the need for those precautions. Seek immediate help for fainting or severe illness, and tell the team every medicine you take.

Questions to settle with your pharmacist or prescriber

  • Is each medicine appropriate for my diagnosis and current health?
  • Does another prescription change my risk or monitoring plan?
  • What should I do during vomiting, dehydration or an upcoming procedure?
  • Which symptoms should trigger a same-day call or urgent care?
  • Does the clinician interpreting my PSA know I take finasteride?

Follow the prescribed schedule. The labels do not require separating this pair by a fixed number of hours, but your pharmacist can help arrange a routine around the rest of your medicines. Do not change doses solely because of a general interaction article.

References

  1. DailyMed: Farxiga prescribing information, updated June 2026.
  2. Organon: Proscar prescribing information, revised March 2026.
  3. Organon: Propecia prescribing information.
  4. MedlinePlus: Dapagliflozin drug information.
Evidence overview for Farxiga and Finasteride Interaction: Safety, Risks, and Clinical Guidance